Marijuana Victims' Association: Is Marijuana the New Thalidomide


VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 4, 2016) - Phocomelia (limb malformation) has been shown in testing* of THC marijuana in a similar preclinical model to that which revealed the teratogenicity of thalidomide.

The federal government is aware of serious marijuana harms; it must not be complicit in risking Canadian health, but must mitigate by placing marijuana products under a protective protocol similar to REVAID used for Thalidomide.

As the stewards of the country's human and financial resources, it is critical that government protect the public from potential irreversible harm and itself from litigation. Marijuana harm is not only possible but probable.

A Health Canada document cites 1,000 scientific references that substantiate the risks.

The June 2016 Government public consultation discussion paper fails to inform the public of the risks, specifically to the fetus and reproduction by males.

If thalidomide offered the "high" of pot would it be reasonable to legalizing it for recreational use?

*Ref: Reece AS, Hulse GK. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. Mutat Res. 2016;789:15-25.

Contact Information:

Marijuana Victims' Association
Pamela McColl
SAM Canada
1-778 354 3551

Company ProfileMarijuana Victims' Association